Broadwood Partners, L.P. - Jan 27, 2025 SCHEDULE 13D/A Report for Lineage Cell Therapeutics, Inc. Common Shares, no par value (LCTX)

Filing Manager
Broadwood Partners, L.P.
Reporting Manager
NEAL C. BRADSHER
Security
Lineage Cell Therapeutics, Inc. Common Shares, no par value
Symbol
LCTX
Shares outstanding
236M shares
Disclosed Ownership
57.8M shares
Ownership
24.5%
Form type
SCHEDULE 13D/A
Date filed
1/28/2025, 08:07 PM
Date of event
Jan 27, 2025
Next filing
Nov 14, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BROADWOOD PARTNERS, L.P. 24.3% 57.5M 0 57.5M /s/ Neal C. Bradsher* Neal C. Bradsher/President of Broadwood Capital, Inc. 0001278386
BROADWOOD CAPITAL, INC. 24.3% 57.5M 0 57.5M /s/ Neal C. Bradsher* Neal C. Bradsher/President 0001278387
NEAL C. BRADSHER 24.5% 57.8M 393K 57.5M /s/ Neal C. Bradsher* Neal C. Bradsher 0001278388